Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis

Overview of attention for article published in Diabetologia, March 2010

Altmetric Badge

Mentioned by

patent: 10 patents

Citations

dimensions_citation: 91 Dimensions

Readers on

mendeley: 85 Mendeley
citeulike: 2 CiteULike

Summary Patents Dimensions citations

So far, Altmetric has seen 10 patents that reference this research output.

Treatment type 2 diabetes mellitus patients

Grant US-10434147-B2

United States of America

Treatment of type 2 diabetes mellitus patients

Grant US-10159713-B2

United States of America

Combination of an insulin and a GLP-1 agonist

Grant US-10117909-B2

United States of America

Pharmaceutical composition comprising a GLP-1 agonist, an insulin and methionine

Grant US-10029011-B2

United States of America

Pharmaceutical composition comprising a GLP-1-agonist and methionine

Grant US-10028910-B2

United States of America

Pharmaceutical composition for use in the treatment of a neurodegenerative disease

Grant US-9987332-B2

United States of America

Use of AVE0010 for the treatment of diabetes mellitus type 2

Grant US-9981013-B2

United States of America

Insulin glargine/lixisenatide fixed ratio formulation

Grant US-9950039-B2

United States of America

Pharmaceutical combination for improving glycemic control as add-on therapy to basal…

Grant US-9821032-B2

United States of America

Pharmaceutical composition comprising a GLP-1 agonist and methionine

Grant US-9707176-B2

United States of America